After four weeks of treatment POMx decreased prostate cancer xenograft size, tumour vessel density, vascular endothelial growth factor (VEGF) levels and HIF-1 alpha expression, thereby suggesting that POMx has an inhibitory effect on tumour-associated angiogenesis [33]. Here, VEGFA is linked to prostate cancer.